Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01286389 : Caloric Restriction in Obese Patients With Mild Cognitive Impairment: Effects on Adiposity, Comorbidity and Cognition
PhaseN/A
AgesMin: 60 Years Max: N/A
Eligibility
Inclusion Criteria:

- body mass index (BMI) ? 27 kg/m2 and a waist circumference greater than or equal to
102 cm for men and 88 cm for women; or BMI ? 30kg/m2;

- independent for most of the instrumental activities of daily life;

- literate;

- able to walk,

- diagnosis of mild cognitive impairment

Exclusion Criteria:

- weight loss greater than 3 kg over the past two months,

- presence of uncontrolled disease that potentially interfere with metabolism and
weight gain or whose treatment would influence the cognitive performance, such as
major depression, bulimia, hypothyroidism, Cushing's disease, heart failure,
neoplasia in the last 3 years, alcoholism, infectious diseases and auto-immune
activity;

- use of anti-obesity drugs, benzodiazepines, neuroleptics or estrogen replacement
therapy in the past 2 months;

- previous bariatric surgery,

- severe sensory deficit
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01286389      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740